Today: 29 April 2026
Browse Category

ASX:CSL.AX 7 January 2026 - 26 February 2026

CSL share price edges up as buyback keeps ASX heavyweight in play

CSL share price edges up as buyback keeps ASX heavyweight in play

CSL Ltd shares closed up 0.6% at A$146.02 Thursday, near the bottom of their 52-week range. The company disclosed it bought back 79,031 shares Wednesday for about A$11.5 million, bringing total repurchases since September to 3.70 million shares. CSL’s half-year report earlier this month showed a 7% drop in underlying NPATA and US$1.1 billion in after-tax impairments. The stock trades ex-dividend March 10.
26 February 2026
···
Why CSL’s share price is moving: Lilly clazakizumab deal, buyback pace and the next dividend date

Why CSL’s share price is moving: Lilly clazakizumab deal, buyback pace and the next dividend date

CSL shares closed up 0.95% at A$154.19 in Sydney, marking a second consecutive gain after announcing a US$100 million licensing deal with Eli Lilly for clazakizumab. ASX filings showed CSL continued its share buyback and a director increased holdings. The stock remains about 15% below early-February levels. CEO Paul McKenzie is set to retire, with Gordon Naylor named interim chief.
19 February 2026
···
CSL shares slide as CEO Paul McKenzie retires, Gordon Naylor named interim ahead of results

CSL shares slide as CEO Paul McKenzie retires, Gordon Naylor named interim ahead of results

CSL said CEO Paul McKenzie will retire, appointing Gordon Naylor as interim chief from Feb. 11. Shares closed down 4.98% after the announcement, which came after market close. Naylor, a former Seqirus and finance head, will lead Wednesday’s half-year results briefing. The leadership change follows weak U.S. flu vaccine demand and delayed plans to spin off Seqirus.
10 February 2026
··
CSL share price ends higher after Vanguard lifts stake — here’s what to watch next

CSL share price ends higher after Vanguard lifts stake — here’s what to watch next

CSL Limited closed up 1.13% at A$181.42 in Sydney, with shares moving on sector momentum and increased institutional ownership after Vanguard disclosed a 6% stake. No new trading update was issued. Investors await CSL’s half-year results and interim dividend announcement on Feb. 11. The stock remains volatile after an October profit downgrade and vaccine unit spin-off delay.
31 January 2026
·
CSL share price ticks higher — but the real test is Feb 11

CSL share price ticks higher — but the real test is Feb 11

CSL Ltd shares closed up 0.46% at A$175.10 on Monday, with about 376,000 shares traded. The move comes ahead of CSL’s half-year results and interim dividend announcement set for Feb. 11. The S&P/ASX 200 finished 0.48% higher, led by gold and consumer stocks, as spot gold hit a 2026 record. CSL’s outlook remains cautious after last year’s guidance cut and delayed Seqirus spin-off.
12 January 2026
·

Stock Market Today

  • April FOMC US Index Levels Update: Dow Jones, Nasdaq, S&P 500
    April 29, 2026, 1:36 PM EDT. Stocks face volatility ahead of key earnings reports from tech giants Meta, Alphabet, Amazon, and Microsoft after market close. Investors seek signs that massive infrastructure spending and AI investments, fueled by trillions of dollars, are generating expected returns. This scrutiny recalls the 2025 AI/Tech crash triggered by unmet high expectations. Meanwhile, geopolitical tensions persist as the US-Iran standoff affects the Strait of Hormuz, pushing oil prices above $105 per barrel. Elevated crude prices raise concerns over inflation and market stability. The market waits on April FOMC signals and intraday performance metrics for the Dow Jones, Nasdaq, and S&P 500 to gauge risk appetite amid these economic and geopolitical pressures.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Go toTop